WashU Medicine faculty elected to American Society for Clinical Investigation
Three physician-scientists at WashU Medicine — neurologists Suzanne
Schindler and Christopher Smyser and otolaryngologist Sidharth Puram — have
been recognized by one of the nation’s oldest and most respected medical honor societies.
Brain’s dynamics can be accurately tracked from a mouse’s eyes
WashU Medicine researchers led by Ryan Raut show that it is possible to accurately predict the state of brain activity by tracking variations in an animal’s pupil dilation, suggesting that brain circuits and the body are more dynamic and interrelated than previously thought.
Class Act: Ariel Hernandez-Leyva
In May, Ariel Hernandez-Leyva is set to achieve his goal of becoming a physician-scientist by earning a medical degree and a PhD in computational and systems biology from WashU Medicine. He is first author on a study — published in the prestigious journal Cell Metabolism — revealing that breath can carry clues to gut microbiome health, particularly among children.
For the tiniest babies, making the best use of antibiotics
A decadeslong research collaboration at WashU Medicine has led to a reduction in antibiotic use in preemies in the neonatal intensive care unit at St. Louis Children’s Hospital.
Huang installed as inaugural Davie professor
Eric Huang, MD, PhD, a leader in the study of human brain development, has been named the inaugural Joseph M. Davie Distinguished Professor in Pathology & Immunology at WashU Medicine.
Unique markers of neurodegenerative disease mapped in blood, spinal fluid
A study led by WashU Medicine researchers reveals molecular insights into Alzheimer’s disease, Parkinson’s disease and other dementias that could lead to earlier, more precise diagnoses.
Supporting runners every step of the way
WashU Medicine serves as the official medical provider — and more — at the Greater St. Louis Marathon.
$12 million NIH grant supports study of Alzheimer’s risk factors
Researchers at WashU Medicine will investigate genetic and molecular factors behind the disease’s disproportionate prevalence in Caribbean populations, with the aim of identifying new drug targets.
Grants bolster research on myelodysplastic syndromes
Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.
mRNA vaccines follow unconventional immune path to destroy tumors
WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.
View More Stories